BDP/formoterol

DRUG2 trials

Sponsors

Chiesi Farmaceutici S.p.A.

Conditions

AsthmaMild Persistent Asthma

Phase 2

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

CompletedNCT01343745

Chiesi Farmaceutici S.p.A.Mild Persistent Asthma

Start: 2008-02-29End: 2008-08-31Updated: 2021-10-29

Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI

CompletedNCT01349257

Chiesi Farmaceutici S.p.A.Asthma

Start: 2011-05-31End: 2011-06-30Updated: 2020-07-31

Related Papers

Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial.

2011-12-2112 citations